Terminal bacterial burden in animals infected with Bcbva. Animals that succumbed to infection in the LD50 studies (n = 23 for CA; n = 25 for CI) were sampled, and mean CFU/ml or g determined for blood, BAL, liver, lung, and spleen tissues. Six survivors were sampled as controls and bacteria were not observed in any of the assayed tissues or fluids at 28 days post-exposure. Data shown are mean with lower and upper 95% confidence intervals in brackets.

Terminal bacterial burden in animals infected with Bcbva. Animals that succumbed to infection in the LD50 studies (n = 23 for CA; n = 25 for CI) were sampled, and mean CFU/ml or g determined for blood, BAL, liver, lung, and spleen tissues. Six survivors were sampled a...

Full description

Saved in:

Bibliographic Details
Main Author:	Allison M. Ferris (21011700) (author)
Other Authors:	David G. Dawson (21011703) (author), Andrea B. Eyler (21011706) (author), John J. Yeager (21011709) (author), Jordan K. Bohannon (5999951) (author), Jeremy A. Boydston (11320726) (author), Melissa L. Krause (21011712) (author), Charles L. Balzli (21011715) (author), Victoria Wahl (11320771) (author), Tammy D. Jenkins (21011718) (author), Sherry L. Rippeon (21011721) (author), James E. Miller (147575) (author), Susan E. Miller (21011724) (author), David W. Clarke (21011727) (author), Emmanuel Manan (11320747) (author), Ashley F. Harman (21011730) (author), Kim R. Rhodes (21011733) (author), Tina M. Sweeney (21011736) (author), Heather D. Cronin (21011739) (author), Ron L. Bowman (21011742) (author), Michael P. Winpigler (21011745) (author), Heather A. Zimmerman (21011748) (author), Alec S. Hail (11320768) (author), Angelo Scorpio (2113660) (author)
Published:	2025
Subjects:	Biochemistry Medicine Microbiology Genetics Molecular Biology Immunology Infectious Diseases Virology Biological Sciences not elsewhere classified Chemical Sciences not elsewhere classified virulence factors harbored virulence factor production new zealand white anthrax vaccine adsorbed quantifying temperature responses evaluate disease course currently available countermeasures disease anthrax due ci ), using bacillus cereus </ bacillus anthracis </ causes inhalational anthrax anthrax mcm efficacies without ava vaccination like disease caused cereus </ anthracis </ like disease pneumonic disease medical countermeasures exposure vaccination disease progression body temperature like plasmids zoonotic organism spores results significant increase progresses quickly possess pxo1 plasmids pxo1 often results medical countermeasure mean time exposure prophylaxis dose dependent data suggest &# 8217
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Similar Items